Researchers used artificial intelligence to create 16 new viruses in laboratory conditions, demonstrating the technology's capability to design biological agents with potential applications in understanding drug resistance. The breakthrough has prompted warnings from security experts about the dual-use risks of making such powerful generative capabilities widely accessible.
Why it matters: This development underscores a critical tension in AI advancement: the same models enabling scientific breakthroughs in virology and drug discovery could be weaponized, forcing the industry and policymakers to grapple with safety protocols and responsible AI deployment in sensitive research domains.